Additionally, ceramide treatment has been found to trigger an increase in ROS, modulate the SOD1/SOD2 ratio, and hinder the proliferation of NSCLC cells, thereby suggesting potential therapeutic avenues [34, 35]. This evidence concerns the gene SOD1 and non-small cell lung carcinoma.